Wegovy fuels sharp rise in use of weight-loss drugs for U.S. youth
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
![Wegovy fuels sharp rise in use of weight-loss drugs for U.S. youth](https://www.ctvnews.ca/polopoly_fs/1.6770221.1708012529!/httpImage/image.jpg_gen/derivatives/landscape_800/image.jpg?#)
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.